Porcine islets for xenotransplantation

Transplantation

Volumn 62, Issue 1, 1996, Pages 136-138

  Maki, Takashi ^a   O'Neil, John J ^b   Porter, Janis ^a   Mullon, Claudy J P ^b   Solomon, Barry A ^b   Monaco, Anthony P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b W R GRACE AND CO CONN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GLUCOSE TOLERANCE TEST; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SWINE; WEIGHT GAIN; XENOGRAFT;

ANIMALS; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DOGS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, NUDE; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029892675     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607150-00028     Document Type: Article

References (10)

1. Novick D, Enelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med 1989; 170: 1409.
2. Novick D, Engelmann H, Revel M, Leitner O, Rubinstein M. Monoclonal antibodies to the soluble IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 1991; 10: 137.
3. Novick D, Shulman L, Chen L, Revel M. Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from human urine and reversion by monoclonal antibodies. Cytokine 1992; 4: 6.
4. Barak V, Ginzburg M, Kalickman I, Polliack A. Serum soluble IL-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Leuk Lymphoma 1992; 7: 431.
5. Belldegrun A, Pierce W, Sayah D, et al. Soluble tumor necrosis factor expression in patients with metastatic renal cell carcinoma treated with IL-2-based immunotherapy. J Immunother 1993; 13: 175.
6. Chasty RC, Lamb WR, Gallati H, Roberts TE, Brenchley PE, Yin JA. Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1993; 12: 331.
7. Novick D, Eshar Z, Revel M, Mory Y. Monoclonal antibodies for affinity purification of IL-6/IFN/32 and for neutralization of HGF activity. Hybridoma 1989; 8: 561.
8. Nagler A, Or R, Nisman B, Kalickman I, Slavin S, Barak V. Elevated inflammatory cytokine levels in bone marrow graft rejection. Transplant 1995; 60: 943.
9. Martinez OM, Krans SM, Sterneck M. Intragraft cytokine profile during human liver allograft rejection. Transplant 1992; 53: 449.
10. Barak V, Levi-Schaffer F, Nisman B, Nagler A. Cytokine dysregulation in chronic graft-versus-host disease. Leuk Lymphoma 1995; 17: 169.